Drs. Anand Srivastava and Prabhat Soni write in a medical journal on the potential benefits of stem cells in fighting against COVID-19. GIOSTAR recently received FDA Approval Under Compassionate Use to treat COVID-19 patients under compassionate use.
GIOSTAR Co-Founder Dr. Anand Srivastava discusses his ground-breaking research on creating red blood cells from stem cells. This innovation has the potential to eradicate diseases worldwide by solving three central problems with blood transfusion.
During this time, many of us are quarantined at home. Some of us are feeling isolated, others depressed, and some even fearful. Truthfully, these are justified feelings, as we are facing some very challenging times. However, there is one simple action that can help you […]
You may have heard the term “functional medicine,” but may not be sure exactly what it is. Shouldn’t all medicine be functional? Of course, but unfortunately conventional medicine focuses primarily on the symptoms – and not the root cause – of disease. Conventional medicine seems […]
GIOSTAR is the leader in developing the most advanced stem cell-based technologies, supported by prominent scientists and physicians trained at leading universities in U.S.A.
